CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
September 2023—Siemens Healthineers announced that its Atellica CI analyzer for immunoassay and clinical chemistry testing has received FDA clearance and is available in many countries.
The analyzer makes it possible for standalone labs and satellite labs of wider health networks to have the same reagents, consumables, and intelligent software as the company’s flagship Atellica solution.
The Atellica CI features random access sampling, microvolume aspiration, and automatic maintenance and quality control scheduling to enable labs to deliver more predictable sample turnaround times. Chemistry and immunoassay engines run independently so throughput is not compromised if one of the two needs to stop. More than 50 assays can deliver results in less than 14 minutes.
The analyzer is equipped with the Atellica Laboratory Evaluation Suite to deliver inspection-ready reports that help labs meet accreditation guidelines. User authentication, role-based authorizations, and audit trails are available for increased security.
Siemens Healthineers, 800-888-7436